Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Red Blood Cell Transfusion in ECMO - A Feasibility Trial

NCT05814094 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT05814094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05814094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Not applicable
Overall status
Recruiting
Start date
September 20, 2023
Completion date
December 30, 2025
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss anemia, cognitive ability, general, disability physical, extracorporeal membrane oxygenation complication, functional status